関連する実験動画
がん患者のうつ病の管理 (SMaRT腫瘍学1):ランダム化試験
Vanessa Strong1, Rachel Waters, Carina Hibberd
1University of Edinburgh Cancer Research Centre, Western General Hospital, Crewe Road, Edinburgh, UK.
Lancet (London, England)
|July 8, 2008
まとめ
看護師による介入は,がん患者のうつ病を大幅に軽減しました. このがん患者のためのうつ病ケアモデルは,疾患のある人の主要なうつ病障害の管理に,実行可能で,受け入れられ,費用対効果が高くなります.
科学分野:
- 腫瘍学 腫瘍学
- 精神科医は精神病を患っている.
- 健康経済学 医療経済学
背景:
- メジャーうつ病 (MDD) は,がん患者の生活の質に大きな影響を与えます.
- 医学的に複雑な患者のMDD管理に関する証拠は限られている.
- この研究では,がん患者のMDDに対する看護師による介入を評価した.
研究 の 目的:
- がん患者における重度のうつ病障害 (MDD) の看護師による複合的な介入の有効性を評価する.
- この介入の費用対効果を判断する.
- 介入が不安,疲労,痛み,身体機能に与える影響を評価する.
主な方法:
- イギリスの地域がんセンターでランダム化試験が行われました.
- 癌とMDDの200人の門診患者は,通常のケアまたは通常のケアと介入にランダムに割り当てられました.
- この介入には,がん看護師が平均7回のセッションを行いましたが,主なアウトカムは3ヶ月後のうつ病スコアでした.
主要な成果:
- 介入グループでは,うつ病のスコアが3ヶ月で著しく低下した (調整差:0.34,95%CI 0.13-0.55).
- この抗うつ薬の効果は,6ヶ月と12ヶ月で持続しました.
- この介入は,不安や疲労を改善したが,痛みや身体機能は改善しなかった.
結論:
- "がん患者のうつ病ケア"介入は,がん患者のMDDを管理するための実現可能で受け入れられるモデルです.
- このアプローチは,専門医療サービス内の患者における重度うつ病の管理に潜在的費用対効果を示しています.
- この発見は,腫瘍学の環境における精神衛生の総合的なケアのための貴重なモデルを示唆しています.
関連する概念動画
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Depression: Overview
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...